Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $3.2 million.

  • Axogen's Cash from Operations fell 1738.02% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 24756.29%. This contributed to the annual value of $4.5 million for FY2024, which is 17933.87% up from last year.
  • Axogen's Cash from Operations amounted to $3.2 million in Q3 2025, which was down 1738.02% from $7.7 million recorded in Q2 2025.
  • In the past 5 years, Axogen's Cash from Operations registered a high of $8.7 million during Q4 2024, and its lowest value of -$13.2 million during Q1 2025.
  • In the last 5 years, Axogen's Cash from Operations had a median value of -$376000.0 in 2021 and averaged -$1.7 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 71841.73% in 2022, then soared by 423981.04% in 2024.
  • Axogen's Cash from Operations (Quarter) stood at -$1.5 million in 2021, then surged by 189.96% to $1.4 million in 2022, then crashed by 115.49% to -$211000.0 in 2023, then surged by 4239.81% to $8.7 million in 2024, then plummeted by 63.1% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $7.7 million for Q2 2025, and -$13.2 million during Q1 2025.